Epidermal growth factor (EGF) as a potential targeting agent for delivery of boron to malignant gliomas
Conference
·
OSTI ID:207597
- Ohio State Univ., Columbus, OH (United States)
- Uppsala Univ. (Sweden). Dept. of Radiation Sciences
The majority of high grade gliomas express an amplified epidermal growth factor receptor (EGFR) gene, and this often is associated with an increase in cell surface receptor expression. The rapid internalization and degradation of EGF-EGFR complexes, as well as their high affinity make EGF a potential targeting agent for delivery of {sup 10}B to tumor cells with an amplified number of EGFR. Human glioma cells can expresses as many as 10{sup 5} {minus}10{sup 6} EGF receptors per cell, and if these could be saturated with boronated EGF, then > 10{sup 8} boron atoms would be delivered per cell. Since EGF has a comparatively low molecular weight ({approximately} 6 kD), this has allowed us to construct relatively small bioconjugates containing {approximately} 900 boron atoms per EGF molecule{sup 3}, which also had high affinity for EGFR on tumor cells. In the present study, the feasibility of using EGF receptors as a potential target for therapy of gliomas was investigated by in vivo scintigraphic studies using {sup 131}I{minus} or {sup 99m}{Tc}-labeled EGF in a rat brain tumor model. Our results indicate that intratumorally delivered boron- EGF conjugates might be useful for targeting EGFR on glioma cells if the boron containing moiety of the conjugates persisted intracellularly. Further studies are required, however, to determine if this approach can be used for BNCT of the rat glioma.
- Research Organization:
- Brookhaven National Lab., Upton, NY (United States)
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- DOE Contract Number:
- AC02-76CH00016
- OSTI ID:
- 207597
- Report Number(s):
- BNL--62807; CONF-9410281--4; ON: DE96008212
- Country of Publication:
- United States
- Language:
- English
Similar Records
Evaluation of boronated EGF as a potential delivery agent for BNCT of brain tumors
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification
Development of Cu-64 labeled EGF for In Vivo PET Imaging of EGFR Expression
Conference
·
Mon Dec 30 23:00:00 EST 1996
·
OSTI ID:539879
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification
Journal Article
·
Thu Oct 01 00:00:00 EDT 1987
· Proc. Natl. Acad. Sci. U.S.A.; (United States)
·
OSTI ID:7241377
Development of Cu-64 labeled EGF for In Vivo PET Imaging of EGFR Expression
Technical Report
·
Sun Jul 12 00:00:00 EDT 2009
·
OSTI ID:958568